Order,AKR,Taxonomy,Res.(Ã…),Complex,PDB
1,"Akr1a1, Akr1a4",Mus musculus,1.64,High resolution structure of mouse aldehyde reductase (AKR1a4) in its apo-form,"<a href=""https://www.rcsb.org/structure/4GAC"">4GAC</a>"
2,"AKR1A1, ALDR1, ALR",Homo sapiens,2.48,ALDEHYDE REDUCTASE,"<a href=""https://www.rcsb.org/structure/2ALR"">2ALR</a>"
3,"AKR1A1, ALR, ALR1",Sus scrofa,2.4,"ALDEHYDE REDUCTASE COMPLEXED WITH COFACTOR AND INHIBITOR, ALPHA CARBON ATOMS ONLY","<a href=""https://www.rcsb.org/structure/1AE4"">1AE4</a>"
4,"AKR1A1, ALR, ALR1",Sus scrofa,2,CRYSTAL STRUCTURE OF PORCINE ALDEHYDE REDUCTASE HOLOENZYME,"<a href=""https://www.rcsb.org/structure/1CWN"">1CWN</a>"
5,"AKR1A1, ALR, ALR1",Sus scrofa,2.2,THE CRYSTAL STRUCTURE OF AN ALDEHYDE REDUCTASE Y50F MUTANT-NADP COMPLEX AND ITS IMPLICATIONS FOR SUBSTRATE BINDING,"<a href=""https://www.rcsb.org/structure/1HQT"">1HQT</a>"
6,"AKR1A1, ALR, ALR1",Sus scrofa,2.41,Crystal structure of porcine aldehyde reductase ternary complex,"<a href=""https://www.rcsb.org/structure/3CV7"">3CV7</a>"
7,"AKR1A1, ALR, ALR1",Sus scrofa,1.99,Porcine aldehyde reductase in ternary complex with inhibitor,"<a href=""https://www.rcsb.org/structure/3FX4"">3FX4</a>"
8,"AKR1A1, ALR, ALR1",Sus scrofa,1.85,Structure of aldehyde reductase holoenzyme in complex with potent aldose reductase inhibitor Fidarestat: Implications for inhibitor binding and selectivity,"<a href=""https://www.rcsb.org/structure/3H4G"">3H4G</a>"
9,"AKR1B1, ALDR1",Homo sapiens,2.4,THE CRYSTAL STRUCTURE OF THE ALDOSE REDUCTASE NADPH BINARY COMPLEX,"<a href=""https://www.rcsb.org/structure/1ABN"">1ABN</a>"
10,"AKR1B1, ALDR1",Homo sapiens,1.65,AN UNLIKELY SUGAR SUBSTRATE SITE IN THE 1.65 ANGSTROMS STRUCTURE OF THE HUMAN ALDOSE REDUCTASE HOLOENZYME IMPLICATED IN DIABETIC COMPLICATIONS,"<a href=""https://www.rcsb.org/structure/1ADS"">1ADS</a>"
11,"AKR1B1, ALDR1",Homo sapiens,1.8,ALRESTATIN BOUND TO C298A/W219Y MUTANT HUMAN ALDOSE REDUCTASE,"<a href=""https://www.rcsb.org/structure/1AZ1"">1AZ1</a>"
12,"AKR1B1, ALDR1",Homo sapiens,2.9,"CITRATE BOUND, C298A/W219Y MUTANT HUMAN ALDOSE REDUCTASE","<a href=""https://www.rcsb.org/structure/1AZ2"">1AZ2</a>"
13,"AKR1B1, ALDR1",Homo sapiens,2.8,FIDARESTAT BOUND TO HUMAN ALDOSE REDUCTASE,"<a href=""https://www.rcsb.org/structure/1EF3"">1EF3</a>"
14,"AKR1B1, ALDR1",Homo sapiens,1.7,HUMAN ALDOSE REDUCTASE COMPLEXED WITH IDD384 INHIBITOR,"<a href=""https://www.rcsb.org/structure/1EL3"">1EL3</a>"
15,"AKR1B1, ALDR1",Homo sapiens,2.5,CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH THE INHIBITOR ZENARESTAT.,"<a href=""https://www.rcsb.org/structure/1IEI"">1IEI</a>"
16,"AKR1B1, ALDR1",Homo sapiens,1.8,REFINED 1.8 ANGSTROMS STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH THE POTENT INHIBITOR ZOPOLRESTAT,"<a href=""https://www.rcsb.org/structure/1MAR"">1MAR</a>"
17,"AKR1B1, ALDR1",Homo sapiens,1.1,Crystal structure of human Aldose Reductase complexed with NADP and Minalrestat,"<a href=""https://www.rcsb.org/structure/1PWL"">1PWL</a>"
18,"AKR1B1, ALDR1",Homo sapiens,0.92,Crystal structure of human Aldose Reductase complexed with NADP and Fidarestat,"<a href=""https://www.rcsb.org/structure/1PWM"">1PWM</a>"
19,"AKR1B1, ALDR1",Homo sapiens,1.8,Crystal structure of human aldose reductase complexed with NADP and IDD552 at ph 5,"<a href=""https://www.rcsb.org/structure/1T40"">1T40</a>"
20,"AKR1B1, ALDR1",Homo sapiens,1.05,Crystal structure of human aldose reductase complexed with NADP and IDD552,"<a href=""https://www.rcsb.org/structure/1T41"">1T41</a>"
21,"AKR1B1, ALDR1",Homo sapiens,0.66,Human Aldose Reductase in complex with NADP+ and the inhibitor IDD594 at 0.66 Angstrom,"<a href=""https://www.rcsb.org/structure/1US0"">1US0</a>"
22,"AKR1B1, ALDR1",Homo sapiens,1.4,Crystal structure of Aldose Reductase with citrates bound in the active site,"<a href=""https://www.rcsb.org/structure/1X96"">1X96</a>"
23,"AKR1B1, ALDR1",Homo sapiens,1.4,"Crystal structure of Aldose Reductase complexed with 2R4S (Stereoisomer of Fidarestat, 2S4S)","<a href=""https://www.rcsb.org/structure/1X97"">1X97</a>"
24,"AKR1B1, ALDR1",Homo sapiens,1.3,"Crystal structure of Aldose Reductase complexed with 2S4R (Stereoisomer of Fidarestat, 2S4S)","<a href=""https://www.rcsb.org/structure/1X98"">1X98</a>"
25,"AKR1B1, ALDR1",Homo sapiens,2.1,Apo R268A human aldose reductase,"<a href=""https://www.rcsb.org/structure/1XGD"">1XGD</a>"
26,"AKR1B1, ALDR1",Homo sapiens,1.04,Human aldose reductase in complex with NADP+ and the inhibitor lidorestat at 1.04 angstrom,"<a href=""https://www.rcsb.org/structure/1Z3N"">1Z3N</a>"
27,"AKR1B1, ALDR1",Homo sapiens,1.43,Human Aldose Reductase complexed with novel Sulfonyl-pyridazinone Inhibitor,"<a href=""https://www.rcsb.org/structure/1Z89"">1Z89</a>"
28,"AKR1B1, ALDR1",Homo sapiens,0.95,Human Aldose Reductase complexed with novel Sulfonyl-pyridazinone Inhibitor,"<a href=""https://www.rcsb.org/structure/1Z8A"">1Z8A</a>"
29,"AKR1B1, ALDR1",Homo sapiens,1.76,"AN ANION BINDING SITE IN HUMAN ALDOSE REDUCTASE: MECHANISTIC IMPLICATIONS FOR THE BINDING OF CITRATE, CACODYLATE, AND GLUCOSE-6-PHOSPHATE","<a href=""https://www.rcsb.org/structure/2ACQ"">2ACQ</a>"
30,"AKR1B1, ALDR1",Homo sapiens,1.76,"AN ANION BINDING SITE IN HUMAN ALDOSE REDUCTASE: MECHANISTIC IMPLICATIONS FOR THE BINDING OF CITRATE, CACODYLATE, AND GLUCOSE-6-PHOSPHATE","<a href=""https://www.rcsb.org/structure/2ACR"">2ACR</a>"
31,"AKR1B1, ALDR1",Homo sapiens,1.76,"AN ANION BINDING SITE IN HUMAN ALDOSE REDUCTASE: MECHANISTIC IMPLICATIONS FOR THE BINDING OF CITRATE, CACODYLATE, AND GLUCOSE-6-PHOSPHATE","<a href=""https://www.rcsb.org/structure/2ACS"">2ACS</a>"
32,"AKR1B1, ALDR1",Homo sapiens,1.76,TYROSINE-48 IS THE PROTON DONOR AND HISTIDINE-110 DIRECTS SUBSTRATE STEREOCHEMICAL SELECTIVITY IN THE REDUCTION REACTION OF HUMAN ALDOSE REDUCTASE: ENZYME KINETICS AND THE CRYSTAL STRUCTURE OF THE Y48H MUTANT ENZYME,"<a href=""https://www.rcsb.org/structure/2ACU"">2ACU</a>"
33,"AKR1B1, ALDR1",Homo sapiens,1,Aldose Reductase Mutant Leu 300 Pro complexed with Fidarestat,"<a href=""https://www.rcsb.org/structure/2AGT"">2AGT</a>"
34,"AKR1B1, ALDR1",Homo sapiens,1.6,Crystal structure of human Aldose Reductase complexed with zopolrestat after 3 days soaking (3days_soaked_1),"<a href=""https://www.rcsb.org/structure/2DUX"">2DUX</a>"
35,"AKR1B1, ALDR1",Homo sapiens,1.6,Human Aldose Reductase complexed with inhibitor zopolrestat after 3 days soaking (3days_soaked_2),"<a href=""https://www.rcsb.org/structure/2DUZ"">2DUZ</a>"
36,"AKR1B1, ALDR1",Homo sapiens,1.62,Human Aldose Reductase complexed with zopolrestat after 6 days soaking(6days_soaked_2),"<a href=""https://www.rcsb.org/structure/2DV0"">2DV0</a>"
37,"AKR1B1, ALDR1",Homo sapiens,1.94,Aldose reductase tertiary complex with NADPH and DEG,"<a href=""https://www.rcsb.org/structure/2F2K"">2F2K</a>"
38,"AKR1B1, ALDR1",Homo sapiens,1.48,Human Aldose reductase complexed with inhibitor zopolrestat at 1.48 A(1 day soaking).,"<a href=""https://www.rcsb.org/structure/2FZ8"">2FZ8</a>"
39,"AKR1B1, ALDR1",Homo sapiens,1.6,Human Aldose Reductase complexed with inhibitor zopolrestat after six days soaking.,"<a href=""https://www.rcsb.org/structure/2FZ9"">2FZ9</a>"
40,"AKR1B1, ALDR1",Homo sapiens,1.5,Human Aldose Reductase complexed with four tolrestat molecules at 1.5 A resolution.,"<a href=""https://www.rcsb.org/structure/2FZB"">2FZB</a>"
41,"AKR1B1, ALDR1",Homo sapiens,1.08,Human aldose reductase complexed with tolrestat at 1.08 A resolution.,"<a href=""https://www.rcsb.org/structure/2FZD"">2FZD</a>"
42,"AKR1B1, ALDR1",Homo sapiens,1.59,Human Aldose Reductase complexed with inhibitor zopolrestat after three days soaking (3days_soaked_3),"<a href=""https://www.rcsb.org/structure/2HV5"">2HV5</a>"
43,"AKR1B1, ALDR1",Homo sapiens,1.58,Human Aldose Reductase-zopolrestat complex obtained by cocrystallisation after one day (1day_cocryst),"<a href=""https://www.rcsb.org/structure/2HVN"">2HVN</a>"
44,"AKR1B1, ALDR1",Homo sapiens,1.65,Human Aldose Reductase-zopolrestat complex obtained by cocrystallisation (10days_cocryst),"<a href=""https://www.rcsb.org/structure/2HVO"">2HVO</a>"
45,"AKR1B1, ALDR1",Homo sapiens,0.81,Human aldose reductase in complex with NADP+ and the inhibitor IDD594 at temperature of 15K,"<a href=""https://www.rcsb.org/structure/2I16"">2I16</a>"
46,"AKR1B1, ALDR1",Homo sapiens,0.81,Human aldose reductase in complex with NADP+ and the inhibitor IDD594 at temperature of 60K,"<a href=""https://www.rcsb.org/structure/2I17"">2I17</a>"
47,"AKR1B1, ALDR1",Homo sapiens,1.43,Aldose reductase complexed with nitrophenyl-oxadiazol type inhibitor at 1.43 A,"<a href=""https://www.rcsb.org/structure/2IKG"">2IKG</a>"
48,"AKR1B1, ALDR1",Homo sapiens,1.55,Human aldose reductase complexed with nitrofuryl-oxadiazol inhibitor at 1.55 A,"<a href=""https://www.rcsb.org/structure/2IKH"">2IKH</a>"
49,"AKR1B1, ALDR1",Homo sapiens,1.47,Human aldose reductase complexed with halogenated IDD-type inhibitor,"<a href=""https://www.rcsb.org/structure/2IKI"">2IKI</a>"
50,"AKR1B1, ALDR1",Homo sapiens,1.55,Human aldose reductase complexed with nitro-substituted IDD-type inhibitor,"<a href=""https://www.rcsb.org/structure/2IKJ"">2IKJ</a>"
51,"AKR1B1, ALDR1",Homo sapiens,1.9,Crystal Structure of Aldose Reductase complexed with Phenylacetic Acid,"<a href=""https://www.rcsb.org/structure/2INE"">2INE</a>"
52,"AKR1B1, ALDR1",Homo sapiens,1.95,Crystal Structure of Aldose Reductase complexed with 2-Hydroxyphenylacetic Acid,"<a href=""https://www.rcsb.org/structure/2INZ"">2INZ</a>"
53,"AKR1B1, ALDR1",Homo sapiens,2,Crystal Structure of C298A W219Y Aldose Reductase complexed with Dichlorophenylacetic acid,"<a href=""https://www.rcsb.org/structure/2IPW"">2IPW</a>"
54,"AKR1B1, ALDR1",Homo sapiens,1.95,Crystal Structure of Aldose Reductase complexed with Hexanoic Acid,"<a href=""https://www.rcsb.org/structure/2IQ0"">2IQ0</a>"
55,"AKR1B1, ALDR1",Homo sapiens,2,Crystal Structure of Aldose Reductase complexed with Lipoic Acid,"<a href=""https://www.rcsb.org/structure/2IQD"">2IQD</a>"
56,"AKR1B1, ALDR1",Homo sapiens,1.7,Crystal Structure of Aldose Reductase complexed with Dichlorophenylacetic acid,"<a href=""https://www.rcsb.org/structure/2IS7"">2IS7</a>"
57,"AKR1B1, ALDR1",Homo sapiens,2,Crystal Structure of C298A W219Y Aldose Reductase complexed with Phenylacetic Acid,"<a href=""https://www.rcsb.org/structure/2ISF"">2ISF</a>"
58,"AKR1B1, ALDR1",Homo sapiens,0.82,Human aldose reductase in complex with NADP and citrate at 0.82 angstrom,"<a href=""https://www.rcsb.org/structure/2J8T"">2J8T</a>"
59,"AKR1B1, ALDR1",Homo sapiens,1.65,"Human Aldose Reductase complexed with novel naphtho[1,2-d]isothiazole acetic acid derivative (3)","<a href=""https://www.rcsb.org/structure/2NVC"">2NVC</a>"
60,"AKR1B1, ALDR1",Homo sapiens,1.55,"Human Aldose Reductase complexed with novel naphtho[1,2-d]isothiazole acetic acid derivative (2)","<a href=""https://www.rcsb.org/structure/2NVD"">2NVD</a>"
61,"AKR1B1, ALDR1",Homo sapiens,1.6,Human aldose reductase mutant V47I complexed with zopolrestat,"<a href=""https://www.rcsb.org/structure/2PD5"">2PD5</a>"
62,"AKR1B1, ALDR1",Homo sapiens,1.55,Human aldose reductase mutant V47I complexed with fidarestat.,"<a href=""https://www.rcsb.org/structure/2PD9"">2PD9</a>"
63,"AKR1B1, ALDR1",Homo sapiens,1.6,Human aldose reductase mutant F121P complexed with zopolrestat.,"<a href=""https://www.rcsb.org/structure/2PDB"">2PDB</a>"
64,"AKR1B1, ALDR1",Homo sapiens,1.65,Human aldose reductase mutant F121P complexed with IDD393.,"<a href=""https://www.rcsb.org/structure/2PDC"">2PDC</a>"
65,"AKR1B1, ALDR1",Homo sapiens,1.56,Human aldose reductase mutant L300P complexed with zopolrestat.,"<a href=""https://www.rcsb.org/structure/2PDF"">2PDF</a>"
66,"AKR1B1, ALDR1",Homo sapiens,1.42,Human aldose reductase with uracil-type inhibitor at 1.42A.,"<a href=""https://www.rcsb.org/structure/2PDG"">2PDG</a>"
67,"AKR1B1, ALDR1",Homo sapiens,1.45,Human aldose reductase mutant L300P complexed with uracil-type inhibitor at 1.45 A.,"<a href=""https://www.rcsb.org/structure/2PDH"">2PDH</a>"
68,"AKR1B1, ALDR1",Homo sapiens,1.55,Human aldose reductase mutant L300A complexed with zopolrestat at 1.55 A.,"<a href=""https://www.rcsb.org/structure/2PDI"">2PDI</a>"
69,"AKR1B1, ALDR1",Homo sapiens,1.57,Human aldose reductase mutant L300A complexed with IDD393.,"<a href=""https://www.rcsb.org/structure/2PDJ"">2PDJ</a>"
70,"AKR1B1, ALDR1",Homo sapiens,1.55,Human aldose reductase mutant L301M complexed with sorbinil.,"<a href=""https://www.rcsb.org/structure/2PDK"">2PDK</a>"
71,"AKR1B1, ALDR1",Homo sapiens,1.47,Human aldose reductase mutant L301M complexed with tolrestat.,"<a href=""https://www.rcsb.org/structure/2PDL"">2PDL</a>"
72,"AKR1B1, ALDR1",Homo sapiens,1.75,Human aldose reductase mutant S302R complexed with zopolrestat.,"<a href=""https://www.rcsb.org/structure/2PDM"">2PDM</a>"
73,"AKR1B1, ALDR1",Homo sapiens,1.7,Human aldose reductase mutant S302R complexed with uracil-type inhibitor.,"<a href=""https://www.rcsb.org/structure/2PDN"">2PDN</a>"
74,"AKR1B1, ALDR1",Homo sapiens,1.65,Human aldose reductase mutant S302R complexed with IDD 393.,"<a href=""https://www.rcsb.org/structure/2PDP"">2PDP</a>"
75,"AKR1B1, ALDR1",Homo sapiens,1.73,Human aldose reductase mutant C303D complexed with uracil-type inhibitor.,"<a href=""https://www.rcsb.org/structure/2PDQ"">2PDQ</a>"
76,"AKR1B1, ALDR1",Homo sapiens,1.55,Human aldose reductase mutant C303D complexed with IDD393.,"<a href=""https://www.rcsb.org/structure/2PDU"">2PDU</a>"
77,"AKR1B1, ALDR1",Homo sapiens,1.55,Human aldose reductase mutant C303D complexed with fidarestat.,"<a href=""https://www.rcsb.org/structure/2PDW"">2PDW</a>"
78,"AKR1B1, ALDR1",Homo sapiens,1.65,Human aldose reductase double mutant S302R-C303D complexed with zopolrestat.,"<a href=""https://www.rcsb.org/structure/2PDX"">2PDX</a>"
79,"AKR1B1, ALDR1",Homo sapiens,1.65,Human aldose reductase double mutant S302R-C303D complexed with fidarestat.,"<a href=""https://www.rcsb.org/structure/2PDY"">2PDY</a>"
80,"AKR1B1, ALDR1",Homo sapiens,0.9,Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat and IDD594. Concentration of Fidarestat in soaking solution exceeds concentration of IDD594.,"<a href=""https://www.rcsb.org/structure/2PEV"">2PEV</a>"
81,"AKR1B1, ALDR1",Homo sapiens,0.85,Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat and IDD594. Concentration of Fidarestat in soaking solution is equal to concentration of IDD594.,"<a href=""https://www.rcsb.org/structure/2PF8"">2PF8</a>"
82,"AKR1B1, ALDR1",Homo sapiens,0.85,Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat and IDD594. Concentration of Fidarestat in soaking solution is less than concentration of IDD594.,"<a href=""https://www.rcsb.org/structure/2PFH"">2PFH</a>"
83,"AKR1B1, ALDR1",Homo sapiens,1,The crystallographic structure of Aldose Reductase IDD393 complex confirms Leu300 as a specificity determinant,"<a href=""https://www.rcsb.org/structure/2PZN"">2PZN</a>"
84,"AKR1B1, ALDR1",Homo sapiens,0.8,Perdeuterated alr2 in complex with idd594,"<a href=""https://www.rcsb.org/structure/2QXW"">2QXW</a>"
85,"AKR1B1, ALDR1",Homo sapiens,,Human Aldose Reductase structure,"<a href=""https://www.rcsb.org/structure/2R24"">2R24</a>"
86,"AKR1B1, ALDR1",Homo sapiens,0.78,"Crystal structure of Aldose Reductase complexed with 2S4R (Stereoisomer of Fidarestat, 2S4S) at 0.78 A","<a href=""https://www.rcsb.org/structure/3BCJ"">3BCJ</a>"
87,"AKR1B1, ALDR1",Homo sapiens,1.45,Aldose Reductase in complex with novel biarylic inhibitor,"<a href=""https://www.rcsb.org/structure/3DN5"">3DN5</a>"
88,"AKR1B1, ALDR1",Homo sapiens,1.8,Human aldose reductase complexed with IDD 740 inhibitor,"<a href=""https://www.rcsb.org/structure/3G5E"">3G5E</a>"
89,"AKR1B1, ALDR1",Homo sapiens,1,Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global effects of radiation damage on protein structure. First stage of radiation damage,"<a href=""https://www.rcsb.org/structure/3GHR"">3GHR</a>"
90,"AKR1B1, ALDR1",Homo sapiens,1,Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global effects of radiation damage on protein structure. Second stage of radiation damage.,"<a href=""https://www.rcsb.org/structure/3GHS"">3GHS</a>"
91,"AKR1B1, ALDR1",Homo sapiens,1.1,Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global effects of radiation damage on protein structure. Third stage of radiation damage.,"<a href=""https://www.rcsb.org/structure/3GHT"">3GHT</a>"
92,"AKR1B1, ALDR1",Homo sapiens,1.2,Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global effects of radiation damage on protein structure. Forth stage of radiation damage.,"<a href=""https://www.rcsb.org/structure/3GHU"">3GHU</a>"
93,"AKR1B1, ALDR1",Homo sapiens,1.1,Human aldose reductase mutant T113C complexed with IDD594,"<a href=""https://www.rcsb.org/structure/3LBO"">3LBO</a>"
94,"AKR1B1, ALDR1",Homo sapiens,1.27,Human aldose reductase mutant T113S complexed with IDD594,"<a href=""https://www.rcsb.org/structure/3LD5"">3LD5</a>"
95,"AKR1B1, ALDR1",Homo sapiens,1.21,Human Aldose Reductase mutant T113S complexed with Zopolrestat,"<a href=""https://www.rcsb.org/structure/3LEN"">3LEN</a>"
96,"AKR1B1, ALDR1",Homo sapiens,0.99,Human Aldose Reductase mutant T113C in complex with IDD388,"<a href=""https://www.rcsb.org/structure/3LEP"">3LEP</a>"
97,"AKR1B1, ALDR1",Homo sapiens,1.35,Human aldose reductase mutant T113A complexed with IDD388,"<a href=""https://www.rcsb.org/structure/3LQG"">3LQG</a>"
98,"AKR1B1, ALDR1",Homo sapiens,1.13,Human Aldose Reductase mutant T113A complexed with IDD 594,"<a href=""https://www.rcsb.org/structure/3LQL"">3LQL</a>"
99,"AKR1B1, ALDR1",Homo sapiens,1.03,Human aldose reductase mutant T113S complexed with IDD388,"<a href=""https://www.rcsb.org/structure/3LZ3"">3LZ3</a>"
100,"AKR1B1, ALDR1",Homo sapiens,0.95,Human aldose reductase mutant T113V complexed with IDD594,"<a href=""https://www.rcsb.org/structure/3LZ5"">3LZ5</a>"
101,"AKR1B1, ALDR1",Homo sapiens,1.07,Human Aldose Reductase mutant T113V in complex with Zopolrestat,"<a href=""https://www.rcsb.org/structure/3M0I"">3M0I</a>"
102,"AKR1B1, ALDR1",Homo sapiens,0.94,Human Aldose Reductase mutant T113V complexed with IDD388,"<a href=""https://www.rcsb.org/structure/3M4H"">3M4H</a>"
103,"AKR1B1, ALDR1",Homo sapiens,1.3,Human aldose reductase mutant T113V complexed with IDD393,"<a href=""https://www.rcsb.org/structure/3M64"">3M64</a>"
104,"AKR1B1, ALDR1",Homo sapiens,1.65,Human Aldose Reductase mutant T113A complexed with Zopolrestat,"<a href=""https://www.rcsb.org/structure/3MB9"">3MB9</a>"
105,"AKR1B1, ALDR1",Homo sapiens,1.14,Human Aldose Reductase mutant T113V in complex with IDD393 crystallized in spacegroup P1,"<a href=""https://www.rcsb.org/structure/3MC5"">3MC5</a>"
106,"AKR1B1, ALDR1",Homo sapiens,1.45,Bond breakage and relocation of a covalently bound bromine of IDD594 in a complex with hAR T113A mutant after extensive radiation dose,"<a href=""https://www.rcsb.org/structure/3ONB"">3ONB</a>"
107,"AKR1B1, ALDR1",Homo sapiens,1.06,Bond breakage and relocation of a covalently bound bromine of IDD594 in a complex with hAR T113A mutant after moderate radiation dose,"<a href=""https://www.rcsb.org/structure/3ONC"">3ONC</a>"
108,"AKR1B1, ALDR1",Homo sapiens,1.69,Novel Benzothiazepine Inhibitor in Complex with human Aldose Reductase,"<a href=""https://www.rcsb.org/structure/3P2V"">3P2V</a>"
109,"AKR1B1, ALDR1",Homo sapiens,2.09,Human Aldose Reductase in Complex with NADP+ in Space Group P212121,"<a href=""https://www.rcsb.org/structure/3Q65"">3Q65</a>"
110,"AKR1B1, ALDR1",Homo sapiens,1.55,Human Aldose Reductase C298S mutant in Complex with NADP+ in Space Group P212121,"<a href=""https://www.rcsb.org/structure/3Q67"">3Q67</a>"
111,"AKR1B1, ALDR1",Homo sapiens,1.9,Crystal Structure of Human Aldose Reductase Complexed with Sulindac Sulfone,"<a href=""https://www.rcsb.org/structure/3RX2"">3RX2</a>"
112,"AKR1B1, ALDR1",Homo sapiens,1.9,Crystal Structure of Human Aldose Reductase Complexed with Sulindac,"<a href=""https://www.rcsb.org/structure/3RX3"">3RX3</a>"
113,"AKR1B1, ALDR1",Homo sapiens,2,Crystal Structure of Human Aldose Reductase complexed with Sulindac Sulfide,"<a href=""https://www.rcsb.org/structure/3RX4"">3RX4</a>"
114,"AKR1B1, ALDR1",Homo sapiens,1.8,Crystal Structure of Human Aldose Reductase Complexed with Tolmetin,"<a href=""https://www.rcsb.org/structure/3S3G"">3S3G</a>"
115,"AKR1B1, ALDR1",Homo sapiens,1.28,Human aldose reductase in complex with a nitrile-containing IDD inhibitor,"<a href=""https://www.rcsb.org/structure/3T42"">3T42</a>"
116,"AKR1B1, ALDR1",Homo sapiens,1,Aldose reductase in complex with NSAID-type inhibitor at 1.0 A resolution,"<a href=""https://www.rcsb.org/structure/3U2C"">3U2C</a>"
117,"AKR1B1, ALDR1",Homo sapiens,1.9,Aldose reductase complexed with a nitro compound,"<a href=""https://www.rcsb.org/structure/3V35"">3V35</a>"
118,"AKR1B1, ALDR1",Homo sapiens,2,Aldose reductase complexed with glceraldehyde,"<a href=""https://www.rcsb.org/structure/3V36"">3V36</a>"
119,"AKR1B1, ALDR1",Homo sapiens,0.9,Complex of Aldose Reductase with inhibitor IDD 1219,"<a href=""https://www.rcsb.org/structure/4GCA"">4GCA</a>"
120,"AKR1B1, ALDR1",Homo sapiens,0.85,Crystal structure of human Aldose Reductase complexed with NADP+ and JF0064,"<a href=""https://www.rcsb.org/structure/4IGS"">4IGS</a>"
121,"AKR1B1, ALDR1",Homo sapiens,2,Crystal Structure Of Aldose Reductase (AKR1B1) Complexed With NADP+ And Epalrestat,"<a href=""https://www.rcsb.org/structure/4JIR"">4JIR</a>"
122,"AKR1B1, ALDR1",Homo sapiens,0.84,Crystal structure of human AR complexed with NADP+ and {2-[(4-bromobenzyl)carbamoyl]-5-chlorophenoxy}acetic acid,"<a href=""https://www.rcsb.org/structure/4LAU"">4LAU</a>"
123,"AKR1B1, ALDR1",Homo sapiens,0.85,Crystal structure of human AR complexed with NADP+ and {5-chloro-2-[(4-iodobenzyl)carbamoyl]phenoxy}acetic acid,"<a href=""https://www.rcsb.org/structure/4LAZ"">4LAZ</a>"
124,"AKR1B1, ALDR1",Homo sapiens,0.8,Crystal structure of human AR complexed with NADP+ and {5-chloro-2-[(2-fluoro-4-iodobenzyl)carbamoyl]phenoxy}acetic acid,"<a href=""https://www.rcsb.org/structure/4LB3"">4LB3</a>"
125,"AKR1B1, ALDR1",Homo sapiens,0.8,"Crystal structure of human AR complexed with NADP+ and {2-[(4-bromo-2,3,5,6-tetrafluorobenzyl)carbamoyl]-5-chlorophenoxy}acetic acid","<a href=""https://www.rcsb.org/structure/4LB4"">4LB4</a>"
126,"AKR1B1, ALDR1",Homo sapiens,0.8,"Crystal structure of human AR complexed with NADP+ and {5-chloro-2-[(2,6-difluoro-4-iodobenzyl)carbamoyl]phenoxy}acetic acid","<a href=""https://www.rcsb.org/structure/4LBR"">4LBR</a>"
127,"AKR1B1, ALDR1",Homo sapiens,0.76,"Crystal structure of human AR complexed with NADP+ and {2-[(4-bromo-2,6-difluorobenzyl)carbamoyl]-5-chlorophenoxy}acetic acid","<a href=""https://www.rcsb.org/structure/4LBS"">4LBS</a>"
128,"AKR1B1, ALDR1",Homo sapiens,1.12,Human Aldose Reductase complexed with Schl7764 at 1.12 A,"<a href=""https://www.rcsb.org/structure/4NKC"">4NKC</a>"
129,"AKR1B1, ALDR1",Homo sapiens,1.06,Human Aldose Reductase complexed with Schl7802 at 1.06 A,"<a href=""https://www.rcsb.org/structure/4PR4"">4PR4</a>"
130,"AKR1B1, ALDR1",Homo sapiens,1.01,Human Aldose Reductase complexed with Schl7815 ((3-[3-(5-NITROFURAN-2-YL)PHENYL]PROPANOIC ACID)at 1.01 A,"<a href=""https://www.rcsb.org/structure/4PRR"">4PRR</a>"
131,"AKR1B1, ALDR1",Homo sapiens,0.96,Human Aldose Reductase complexed with Schl12221 ({2-[5-(3-NITROPHENYL)FURAN-2-YL]PHENYL}ACETIC ACID) at 0.96 A,"<a href=""https://www.rcsb.org/structure/4PRT"">4PRT</a>"
132,"AKR1B1, ALDR1",Homo sapiens,1.14,Human Aldose Reductase complexed with a ligand with an IDD structure (2-(2-carbamoyl-5-fluoro-phenoxy)acetic acid) at 1.14 A,"<a href=""https://www.rcsb.org/structure/4PUU"">4PUU</a>"
133,"AKR1B1, ALDR1",Homo sapiens,1.12,Human Aldose Reductase complexed with a ligand with an IDD structure (2-[5-fluoro-2-(prop-2-ynylcarbamoyl)phenoxy]acetic acid) at 1.12 A,"<a href=""https://www.rcsb.org/structure/4PUW"">4PUW</a>"
134,"AKR1B1, ALDR1",Homo sapiens,1.19,Human Aldose Reductase complexed with a ligand with an IDD structure ([2-(benzylcarbamoyl)-5-fluorophenoxy]acetic acid) at 1.19 A,"<a href=""https://www.rcsb.org/structure/4Q7B"">4Q7B</a>"
135,"AKR1B1, ALDR1",Homo sapiens,0.98,Human Aldose Reductase complexed with a ligand with an IDD structure ({5-fluoro-2-[(3-nitrobenzyl)carbamoyl]phenoxy}acetic acid) at 0.98 A,"<a href=""https://www.rcsb.org/structure/4QBX"">4QBX</a>"
136,"AKR1B1, ALDR1",Homo sapiens,1.05,"Human Aldose Reductase complexed with a ligand with an IDD structure (2-[2-(1,3-benzothiazol-2-ylmethylcarbamoyl)-5-fluoro-phenoxy]acetic acid) at 1.05 A","<a href=""https://www.rcsb.org/structure/4QR6"">4QR6</a>"
137,"AKR1B1, ALDR1",Homo sapiens,1.26,Human Aldose Reductase complexed with a ligand with a new scaffold at 1.26 A,"<a href=""https://www.rcsb.org/structure/4QX4"">4QX4</a>"
138,"AKR1B1, ALDR1",Homo sapiens,0.87,Crystal structure of human AR complexed with NADP+ and AK198,"<a href=""https://www.rcsb.org/structure/4QXI"">4QXI</a>"
139,"AKR1B1, ALDR1",Homo sapiens,1.2,Human Aldose Reductase complexed with a ligand with an IDD structure at 1.20 A (1),"<a href=""https://www.rcsb.org/structure/4RPQ"">4RPQ</a>"
140,"AKR1B1, ALDR1",Homo sapiens,1,Crystal structure of human Aldose Reductase complexed with NADP+ and JF0048,"<a href=""https://www.rcsb.org/structure/4XZH"">4XZH</a>"
141,"AKR1B1, ALDR1",Homo sapiens,2.45,Crystal structure of human Aldose Reductase complexed with NADP+ and JF0049,"<a href=""https://www.rcsb.org/structure/4XZI"">4XZI</a>"
142,"AKR1B1, ALDR1",Homo sapiens,1.07,Human Aldose Reductase complexed with a ligand with an IDD structure (2) at 1.07 A.,"<a href=""https://www.rcsb.org/structure/4YS1"">4YS1</a>"
143,"AKR1B1, ALDR1",Homo sapiens,1.02,Human Aldose Reductase complexed with Schl12134 (3-[5-(3-nitrophenyl)-2-thienyl]propanoic acid) at 1.02 A,"<a href=""https://www.rcsb.org/structure/4YU1"">4YU1</a>"
144,"AKR1B1, ALDR1",Homo sapiens,1.65,Human Aldose Reductase in Complex with NADP+ and WY14643 in Space Group P212121,"<a href=""https://www.rcsb.org/structure/5HA7"">5HA7</a>"
145,"AKR1B1, ALDR1",Homo sapiens,0.94,Crystal structure of human AKR1B1 complexed with NADP+ and compound 37,"<a href=""https://www.rcsb.org/structure/5OU0"">5OU0</a>"
146,"AKR1B1, ALDR1",Homo sapiens,0.96,Crystal structure of human AKR1B1 complexed with NADP+ and compound 39,"<a href=""https://www.rcsb.org/structure/5OUJ"">5OUJ</a>"
147,"AKR1B1, ALDR1",Homo sapiens,0.96,Crystal structure of human AKR1B1 complexed with NADP+ and compound 41,"<a href=""https://www.rcsb.org/structure/5OUK"">5OUK</a>"
148,"AKR1B1, ALR2",Sus scrofa,2.3,PIG ALDOSE REDUCTASE COMPLEXED WITH SORBINIL,"<a href=""https://www.rcsb.org/structure/1AH0"">1AH0</a>"
149,"AKR1B1, ALR2",Sus scrofa,2.3,ALDOSE REDUCTASE COMPLEXED WITH TOLRESTAT INHIBITOR,"<a href=""https://www.rcsb.org/structure/1AH3"">1AH3</a>"
150,"AKR1B1, ALR2",Sus scrofa,2,"PIG ALDOSE REDUCTASE, HOLO FORM","<a href=""https://www.rcsb.org/structure/1AH4"">1AH4</a>"
151,"AKR1B1, ALR2",Sus scrofa,3,NOVEL NADPH-BINDING DOMAIN REVEALED BY THE CRYSTAL STRUCTURE OF ALDOSE REDUCTASE,"<a href=""https://www.rcsb.org/structure/1DLA"">1DLA</a>"
152,"AKR1B1, ALR2",Sus scrofa,2.2,PIG ALDOSE REDUCTASE COMPLEXED WITH IDD384 INHIBITOR,"<a href=""https://www.rcsb.org/structure/1EKO"">1EKO</a>"
153,"AKR1B10, AKR1B11",Homo sapiens,1.25,Crystal Structure Of AKR1B10 Complexed With NADP+ And Tolrestat,"<a href=""https://www.rcsb.org/structure/1ZUA"">1ZUA</a>"
154,"AKR1B10, AKR1B11",Homo sapiens,1.94,Human AKR1B10 mutant V301L complexed with NADP+ and sorbinil,"<a href=""https://www.rcsb.org/structure/4GA8"">4GA8</a>"
155,"AKR1B10, AKR1B11",Homo sapiens,1.6,Human AKR1B10 mutant V301L complexed with NADP+ and fidarestat,"<a href=""https://www.rcsb.org/structure/4GAB"">4GAB</a>"
156,"AKR1B10, AKR1B11",Homo sapiens,2.1,Crystal structure of AKR1B10 complexed with NADP+ and Caffeic acid phenethyl ester,"<a href=""https://www.rcsb.org/structure/4GQ0"">4GQ0</a>"
157,"AKR1B10, AKR1B11",Homo sapiens,1.92,Crystal structure of AKR1B10 complexed with NADP+,"<a href=""https://www.rcsb.org/structure/4GQG"">4GQG</a>"
158,"AKR1B10, AKR1B11",Homo sapiens,2.1,Crystal Structure Of AKR1B10 Complexed With NADP+ And Flufenamic acid,"<a href=""https://www.rcsb.org/structure/4I5X"">4I5X</a>"
159,"AKR1B10, AKR1B11",Homo sapiens,1.75,Crystal structure of human AKR1B10 complexed with NADP+ and JF0064,"<a href=""https://www.rcsb.org/structure/4ICC"">4ICC</a>"
160,"AKR1B10, AKR1B11",Homo sapiens,2.3,Crystal Structure Of AKR1B10 Complexed With NADP+ And Epalrestat,"<a href=""https://www.rcsb.org/structure/4JIH"">4JIH</a>"
161,"AKR1B10, AKR1B11",Homo sapiens,2.2,Crystal Structure Of AKR1B10 Complexed With NADP+ And Zopolrestat,"<a href=""https://www.rcsb.org/structure/4JII"">4JII</a>"
162,"AKR1B10, AKR1B11",Homo sapiens,1.45,Crystal structure of human AKR1B10 complexed with NADP+ and sulindac,"<a href=""https://www.rcsb.org/structure/4WEV"">4WEV</a>"
163,"AKR1B10, AKR1B11",Homo sapiens,1.7,Crystal structure of human AKR1B10 complexed with NADP+ and JF0049,"<a href=""https://www.rcsb.org/structure/4XZL"">4XZL</a>"
164,"AKR1B10, AKR1B11",Homo sapiens,1.75,Crystal structure of the methylated wild-type AKR1B10 holoenzyme,"<a href=""https://www.rcsb.org/structure/4XZM"">4XZM</a>"
165,"AKR1B10, AKR1B11",Homo sapiens,1.7,Crystal structure of the methylated K125R/V301L AKR1B10 Holoenzyme,"<a href=""https://www.rcsb.org/structure/4XZN"">4XZN</a>"
166,"AKR1B10, AKR1B11",Homo sapiens,2.05,Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK181,"<a href=""https://www.rcsb.org/structure/5LIK"">5LIK</a>"
167,"AKR1B10, AKR1B11",Homo sapiens,1.75,Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor IDD388,"<a href=""https://www.rcsb.org/structure/5LIU"">5LIU</a>"
168,"AKR1B10, AKR1B11",Homo sapiens,1.75,Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK319,"<a href=""https://www.rcsb.org/structure/5LIW"">5LIW</a>"
169,"AKR1B10, AKR1B11",Homo sapiens,1.95,Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK184,"<a href=""https://www.rcsb.org/structure/5LIX"">5LIX</a>"
170,"AKR1B10, AKR1B11",Homo sapiens,2.05,Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK204,"<a href=""https://www.rcsb.org/structure/5LIY"">5LIY</a>"
171,"AKR1B10, AKR1B11",Homo sapiens,1.5,Crystal structure of human AKR1B10 complexed with NADP+ and the synthetic retinoid UVI2008,"<a href=""https://www.rcsb.org/structure/5M2F"">5M2F</a>"
172,"AKR1B10, AKR1B11",Homo sapiens,2.5,Crystal structure of AKR1B10 in complex with NADP+ and Androst-4-ene-3-beta-6-alpha-diol,"<a href=""https://www.rcsb.org/structure/5Y7N"">5Y7N</a>"
173,"Akr1b7, Akr1b14",Rattus norvegicus,1.86,Crystal Structure of AKR1B14 in complex with NADP,"<a href=""https://www.rcsb.org/structure/3O3R"">3O3R</a>"
174,"Akr1b7, Akr1b14",Rattus norvegicus,1.87,Crystal structure of mutant His269Arg AKR1B14,"<a href=""https://www.rcsb.org/structure/3QKZ"">3QKZ</a>"
175,AKR1B8,Cricetulus griseus,2.4,CHO REDUCTASE WITH NADP+,"<a href=""https://www.rcsb.org/structure/1C9W"">1C9W</a>"
176,"AKR1C1, DDH, DDH1",Homo sapiens,1.59,Crystal structure of human 20alpha-HSD in ternary complex with NADP and 20alpha-hydroxy-progesterone,"<a href=""https://www.rcsb.org/structure/1MRQ"">1MRQ</a>"
177,"AKR1C1, DDH, DDH1",Homo sapiens,1.8,"Crystal structure of AKR1C1 in complex with NADP and 3,5-dichlorosalicylic acid","<a href=""https://www.rcsb.org/structure/3C3U"">3C3U</a>"
178,"AKR1C1, DDH, DDH1",Homo sapiens,1.9,"Crystal structure of AKR1C1 L308V mutant in complex with NADP and 3,5-dichlorosalicylic acid","<a href=""https://www.rcsb.org/structure/3GUG"">3GUG</a>"
179,"AKR1C1, DDH, DDH1",Homo sapiens,1.87,"Crystal structure of AKR1C1 in complex with NADP and 5-Phenyl,3-chlorosalicylic acid","<a href=""https://www.rcsb.org/structure/3NTY"">3NTY</a>"
180,"AKR1C1, DDH, DDH1",Homo sapiens,2.6,Crystal Structure of AKR1C1 complexed with glibenclamide,"<a href=""https://www.rcsb.org/structure/4YVP"">4YVP</a>"
181,Akr1c13,Mus musculus,1.5,Crystal Structure of mouse RECON (AKR1C13) in complex with Cyclic di-AMP,"<a href=""https://www.rcsb.org/structure/5UXF"">5UXF</a>"
182,"AKR1C2, DDH2",Homo sapiens,3,Crystal Structure of Human Type III 3-alpha-Hydroxysteroid Dehydrogenase/Bile Acid Binding Protein (AKR1C2) Complexed with NADP+ and Ursodeoxycholate,"<a href=""https://www.rcsb.org/structure/1IHI"">1IHI</a>"
183,"AKR1C2, DDH2",Homo sapiens,1.25,Human 3alpha-HSD type 3 in Ternary Complex with NADP and Testosterone,"<a href=""https://www.rcsb.org/structure/1J96"">1J96</a>"
184,"AKR1C2, DDH2",Homo sapiens,1.9,"Crystal structure of human type 3 3alpha-hydroxysteroid dehydrogenase in complex with NADP(H), citrate and acetate molecules","<a href=""https://www.rcsb.org/structure/1XJB"">1XJB</a>"
185,"AKR1C2, DDH2",Homo sapiens,2,Crystal structure of human type 3 3alpha-hydroxysteroid dehydrogenase in complex with NADP(H),"<a href=""https://www.rcsb.org/structure/2HDJ"">2HDJ</a>"
186,"AKR1C2, DDH2",Homo sapiens,1.8,Crystal structure of h3alpha-hydroxysteroid dehydrogenase type 3 mutant Y24A in complex with NADP+ and epi-testosterone,"<a href=""https://www.rcsb.org/structure/2IPJ"">2IPJ</a>"
187,"AKR1C2, DDH2",Homo sapiens,1.6,AKR1C2 complex with naproxen,"<a href=""https://www.rcsb.org/structure/4JQ1"">4JQ1</a>"
188,"AKR1C2, DDH2",Homo sapiens,1.75,AKR1C2 complex with sulindac,"<a href=""https://www.rcsb.org/structure/4JQ2"">4JQ2</a>"
189,"AKR1C2, DDH2",Homo sapiens,1.75,AKR1C2 complex with zomepirac,"<a href=""https://www.rcsb.org/structure/4JQ3"">4JQ3</a>"
190,"AKR1C2, DDH2",Homo sapiens,1.52,AKR1C2 complex with indomethacin,"<a href=""https://www.rcsb.org/structure/4JQ4"">4JQ4</a>"
191,"AKR1C2, DDH2",Homo sapiens,1.45,AKR1C2 complex with mefenamic acid,"<a href=""https://www.rcsb.org/structure/4JQA"">4JQA</a>"
192,"AKR1C2, DDH2",Homo sapiens,1.6,AKR1C2 complex with flurbiprofen,"<a href=""https://www.rcsb.org/structure/4JTQ"">4JTQ</a>"
193,"AKR1C2, DDH2",Homo sapiens,1.3,AKR1C2 complex with ibuprofen,"<a href=""https://www.rcsb.org/structure/4JTR"">4JTR</a>"
194,"AKR1C2, DDH2",Homo sapiens,2.2,Crystal Structuer of Human 3-alpha Hydroxysteroid Dehydrogenase Type 3 in Complex with NADP+ and Progesterone,"<a href=""https://www.rcsb.org/structure/4L1W"">4L1W</a>"
195,"AKR1C2, DDH2",Homo sapiens,2,Crystal Structuer of Human 3-alpha Hydroxysteroid Dehydrogenase Type 3 V54L Mutant in Complex with NADP+ and Progesterone,"<a href=""https://www.rcsb.org/structure/4L1X"">4L1X</a>"
196,"AKR1C2, DDH2",Homo sapiens,1.2,"Crystal structure of human 3-alpha hydroxysteroid dehydrogenase type 3 in complex with NADP+, 5alpha-androstan-3,17-dione and (3beta, 5alpha)-3-hydroxyandrostan-17-one","<a href=""https://www.rcsb.org/structure/4XO6"">4XO6</a>"
197,"AKR1C2, DDH2",Homo sapiens,1.75,"Crystal structure of human 3-alpha hydroxysteroid dehydrogenase type 3 in complex with NADP+, 5alpha-androstan-3,17-dione and (3beta, 5alpha)-3-hydroxyandrostan-17-one","<a href=""https://www.rcsb.org/structure/4XO7"">4XO7</a>"
198,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,1.69,Structure of prostaglandin F synthase with prostaglandin D2,"<a href=""https://www.rcsb.org/structure/1RY0"">1RY0</a>"
199,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,1.69,Prostaglandin F synthase complexed with NADPH and rutin,"<a href=""https://www.rcsb.org/structure/1RY8"">1RY8</a>"
200,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,1.2,Crystal structures of prostaglandin D2 11-ketoreductase (AKR1C3) in complex with the non-steroidal anti-inflammatory drugs flufenamic acid and indomethacin,"<a href=""https://www.rcsb.org/structure/1S1P"">1S1P</a>"
201,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,2,Crystal structures of prostaglandin D2 11-ketoreductase (AKR1C3) in complex with the non-steroidal anti-inflammatory drugs flufenamic acid and indomethacin,"<a href=""https://www.rcsb.org/structure/1S1R"">1S1R</a>"
202,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,1.7,Crystal structures of prostaglandin D2 11-ketoreductase in complex with the non-steroidal anti-inflammatory drugs flufenamic acid and indomethacin,"<a href=""https://www.rcsb.org/structure/1S2A"">1S2A</a>"
203,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,1.8,Crystal structures of prostaglandin D2 11-ketoreductase in complex with the non-steroidal anti-inflammatory drugs flufenamic acid and indomethacin,"<a href=""https://www.rcsb.org/structure/1S2C"">1S2C</a>"
204,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,2,"Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 (AKR1C3) complexed with delta4-androstene-3,17-dione and NADP","<a href=""https://www.rcsb.org/structure/1XF0"">1XF0</a>"
205,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,1.3,Crystal structure of human androgenic 17beta-hydroxysteroid dehydrogenase type 5 in complexed with a potent inhibitor EM1404,"<a href=""https://www.rcsb.org/structure/1ZQ5"">1ZQ5</a>"
206,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,2,Crystal structure of prostaglandin F synathase containing bimatoprost,"<a href=""https://www.rcsb.org/structure/2F38"">2F38</a>"
207,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,1.35,Crystal structure of human 17bet a-hydroxysteroid dehydrogenase type 5 in complexes with PEG and NADP,"<a href=""https://www.rcsb.org/structure/2FGB"">2FGB</a>"
208,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,2,AKR1C3 complexed with mefenamic acid,"<a href=""https://www.rcsb.org/structure/3R43"">3R43</a>"
209,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,2.3,AKR1C3 complex with naproxen,"<a href=""https://www.rcsb.org/structure/3R58"">3R58</a>"
210,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,1.95,AKR1C3 complex with meclofenamic acid,"<a href=""https://www.rcsb.org/structure/3R6I"">3R6I</a>"
211,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,2.1,AKR1C3 complex with sulindac,"<a href=""https://www.rcsb.org/structure/3R7M"">3R7M</a>"
212,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,1.8,AKR1C3 complex with ibuprofen,"<a href=""https://www.rcsb.org/structure/3R8G"">3R8G</a>"
213,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,1.9,AKR1C3 complex with zomepirac,"<a href=""https://www.rcsb.org/structure/3R8H"">3R8H</a>"
214,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,2.01,AKR1C3 complex with flurbiprofen,"<a href=""https://www.rcsb.org/structure/3R94"">3R94</a>"
215,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,1.9,AKR1C3 complex with R-naproxen,"<a href=""https://www.rcsb.org/structure/3UFY"">3UFY</a>"
216,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,1.73,AKR1C3 complex with indomethacin at pH 7.5,"<a href=""https://www.rcsb.org/structure/3UG8"">3UG8</a>"
217,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,1.65,AKR1C3 complex with indomethacin at pH 6.8,"<a href=""https://www.rcsb.org/structure/3UGR"">3UGR</a>"
218,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,1.68,AKR1C3 complexed with 3-phenoxybenzoic acid,"<a href=""https://www.rcsb.org/structure/3UWE"">3UWE</a>"
219,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,1.85,Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 (AKR1C3) in complex with NADP+ and 3'-[(4-nitronaphthalen-1-yl)amino]benzoic acid,"<a href=""https://www.rcsb.org/structure/4DBS"">4DBS</a>"
220,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,2.53,Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 (AKR1C3) in complex with NADP+ and 3-((4 -(trifluoromethyl)phenyl)amino)benzoic acid,"<a href=""https://www.rcsb.org/structure/4DBU"">4DBU</a>"
221,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,1.8,Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 (AKR1C3) in complex with NADP+ and 2'-desmethyl-indomethacin,"<a href=""https://www.rcsb.org/structure/4DBW"">4DBW</a>"
222,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,1.7,W227F active site mutant of AKR1C3,"<a href=""https://www.rcsb.org/structure/4DZ5"">4DZ5</a>"
223,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,2.2,Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with (R)-1-(naphthalen-2-ylsulfonyl)piperidine-3-carboxylic acid (86),"<a href=""https://www.rcsb.org/structure/4FA3"">4FA3</a>"
224,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,2,"Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with 3-((3,4-dihydroisoquinolin-2(1H)-yl)sulfonyl)-N-methylbenzamide (80)","<a href=""https://www.rcsb.org/structure/4FAL"">4FAL</a>"
225,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,2,"Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with 3-((3,4-dihydroisoquinolin-2(1H)-yl)sulfonyl)benzoic acid (17)","<a href=""https://www.rcsb.org/structure/4FAM"">4FAM</a>"
226,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,1.97,Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with 1-{4-[(2-methyl-1-piperidinyl)sulfonyl]phenyl}-2-pyrrolidinone,"<a href=""https://www.rcsb.org/structure/4H7C"">4H7C</a>"
227,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,2.4,Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with (4-(4-Chlorophenyl)piperazin-1-yl)(morpholino)methanone (24),"<a href=""https://www.rcsb.org/structure/4HMN"">4HMN</a>"
228,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,1.5,17beta-HSD5 in complex with 2-nitro-5-(phenylsulfonyl)phenol,"<a href=""https://www.rcsb.org/structure/4WDT"">4WDT</a>"
229,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,1.7,17beta-HSD5 in complex with 4-chloro-N-(4-chlorobenzyl)-5-nitro-1H-pyrazole-3-carboxamide,"<a href=""https://www.rcsb.org/structure/4WDU"">4WDU</a>"
230,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,1.94,"17beta-HSD5 in complex with 3,6-dihydropyridin-1(2H)-yl(5-methyl-1H-indol-2-yl)methanone","<a href=""https://www.rcsb.org/structure/4WDW"">4WDW</a>"
231,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,1.64,17beta-HSD5 in complex with [4-(2-hydroxyethyl)piperidin-1-yl](5-methyl-1H-indol-2-yl)methanone,"<a href=""https://www.rcsb.org/structure/4WDX"">4WDX</a>"
232,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,1.6,"AKR1C3 complexed with breakdown product of N-(tert-butyl)-2-(2-chloro-4-(((3-mercapto-5-methyl-4H-1,2,4-triazol-4-yl)amino)methyl)-6-methoxyphenoxy)acetamide","<a href=""https://www.rcsb.org/structure/4WRH"">4WRH</a>"
233,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,2.81,17beta-HSD5 in complex with 4-nitro-2-({4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}methyl)phenol,"<a href=""https://www.rcsb.org/structure/4XVD"">4XVD</a>"
234,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,1.55,17beta-HSD5 in complex with 3-pentyl-2-[(pyridin-2-ylmethyl)sulfanyl]-7-(pyrrolidin-1-ylcarbonyl)quinazolin-4(3H)-one,"<a href=""https://www.rcsb.org/structure/4XVE"">4XVE</a>"
235,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,2.3,Crystal structure of AKR1C3 complexed with glibenclamide,"<a href=""https://www.rcsb.org/structure/4YVV"">4YVV</a>"
236,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,2.3,Crystal structure of AKR1C3 complexed with glimepiride,"<a href=""https://www.rcsb.org/structure/4YVX"">4YVX</a>"
237,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,2,Crystal structure of AKR1C3 complexed with glicazide,"<a href=""https://www.rcsb.org/structure/4ZFC"">4ZFC</a>"
238,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,2,Crystal Structure of AKR1C3 complexed with CAPE,"<a href=""https://www.rcsb.org/structure/5HNT"">5HNT</a>"
239,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,2,Crystal Structure of AKR1C3 complexed with octyl gallate,"<a href=""https://www.rcsb.org/structure/5HNU"">5HNU</a>"
240,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,1.99,Crystal structure of AKR1C3 complexed with a pro-drug,"<a href=""https://www.rcsb.org/structure/5JM5"">5JM5</a>"
241,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,1.88,Potent and selective Aldo-Keto Reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a Bioisosteric Scaffold Hopping Approach to Flufenamic acid,"<a href=""https://www.rcsb.org/structure/6F2U"">6F2U</a>"
242,"AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS",Homo sapiens,1.3,Potent and selective Aldo-Keto Reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: Application of a Bioisosteric Scaffold Hopping Approach to Flufenamic acid,"<a href=""https://www.rcsb.org/structure/6F78"">6F78</a>"
243,"AKR1C4, CHDR",Homo sapiens,2.4,Crystal structure of human 3-alpha hydroxysteroid/dihydrodiol dehydrogenase (AKR1C4) complexed with NADP+,"<a href=""https://www.rcsb.org/structure/2FVL"">2FVL</a>"
244,AKR1C5,Oryctolagus cuniculus,2.08,Crystal structure of rabbit 20alpha hyroxysteroid dehydrogenase in ternary complex with NADP and testosterone,"<a href=""https://www.rcsb.org/structure/1Q13"">1Q13</a>"
245,AKR1C5,Oryctolagus cuniculus,1.32,Binary complex of rabbit 20alpha-hydroxysteroid dehydrogenase with NADPH,"<a href=""https://www.rcsb.org/structure/1Q5M"">1Q5M</a>"
246,"AKR1D1, SRD5B1",Homo sapiens,1.62,Crystal structure of Delta(4)-3-ketosteroid 5-beta-reductase in complex with NADP and TESTOSTERONE. RESOLUTION: 1.62 A.,"<a href=""https://www.rcsb.org/structure/3BUR"">3BUR</a>"
247,"AKR1D1, SRD5B1",Homo sapiens,1.35,Crystal structure of human Delta(4)-3-ketosteroid 5-beta-reductase in complex with NADP and HEPES. Resolution: 1.35 A.,"<a href=""https://www.rcsb.org/structure/3BUV"">3BUV</a>"
248,"AKR1D1, SRD5B1",Homo sapiens,1.79,Crystal structure of Delta(4)-3-ketosteroid 5-beta-reductase in complex with NADP and glycerol. Resolution: 1.79 A.,"<a href=""https://www.rcsb.org/structure/3BV7"">3BV7</a>"
249,"AKR1D1, SRD5B1",Homo sapiens,2.2,Crystal structure of 5beta-reductase (AKR1D1) in complex with NADPH,"<a href=""https://www.rcsb.org/structure/3CAQ"">3CAQ</a>"
250,"AKR1D1, SRD5B1",Homo sapiens,2,Crystal structure of 5beta-reductase (AKR1D1) in complex with NADP+ and 4-androstenedione,"<a href=""https://www.rcsb.org/structure/3CAS"">3CAS</a>"
251,"AKR1D1, SRD5B1",Homo sapiens,1.9,"Crystal structure of 5beta-reductase (AKR1D1) in complex with NADP+ and 5beta-pregnan-3,20-dione","<a href=""https://www.rcsb.org/structure/3CAV"">3CAV</a>"
252,"AKR1D1, SRD5B1",Homo sapiens,1.9,Crystal structure of human liver 5beta-reductase (AKR1D1) in complex with NADP and CORTISONE. Resolution 1.90 A.,"<a href=""https://www.rcsb.org/structure/3CMF"">3CMF</a>"
253,"AKR1D1, SRD5B1",Homo sapiens,2.03,Crystal structure of human liver delta(4)-3-ketosteroid 5beta-reductase (akr1d1) in complex with progesterone and nadp. Resolution: 2.03 A.,"<a href=""https://www.rcsb.org/structure/3COT"">3COT</a>"
254,"AKR1D1, SRD5B1",Homo sapiens,2,"Crystal structure of 5beta-reductase (AKR1D1) in complex with NADP+ and 5beta-dihydrotestosterone, Resolution 2.00A","<a href=""https://www.rcsb.org/structure/3DOP"">3DOP</a>"
255,"AKR1D1, SRD5B1",Homo sapiens,1.7,Crystal structure of human liver 5beta-reductase (AKR1D1) in complex with NADP and Finasteride. Resolution 1.70 A,"<a href=""https://www.rcsb.org/structure/3G1R"">3G1R</a>"
256,"AKR1D1, SRD5B1",Homo sapiens,1.89,Crystal structure of 5beta-reductase (AKR1D1) E120H mutant in complex with NADP+,"<a href=""https://www.rcsb.org/structure/3UZW"">3UZW</a>"
257,"AKR1D1, SRD5B1",Homo sapiens,1.64,Crystal structure of 5beta-reductase (AKR1D1) E120H mutant in complex with NADP+ and epiandrosterone,"<a href=""https://www.rcsb.org/structure/3UZX"">3UZX</a>"
258,"AKR1D1, SRD5B1",Homo sapiens,1.83,Crystal structure of 5beta-reductase (AKR1D1) E120H mutant in complex with NADP+ and 5beta-dihydrotestosterone,"<a href=""https://www.rcsb.org/structure/3UZY"">3UZY</a>"
259,"AKR1D1, SRD5B1",Homo sapiens,1.82,Crystal structure of 5beta-reductase (AKR1D1) E120H mutant in complex with NADP+ and delta4-androstenedione,"<a href=""https://www.rcsb.org/structure/3UZZ"">3UZZ</a>"
260,"AKR2A, AFT, AKR2, At4g35450, F15J1.20",Arabidopsis thaliana,2.3,Crystal structure of Ankyrin Repeat Domain of AKR2,"<a href=""https://www.rcsb.org/structure/4TUM"">4TUM</a>"
261,"AKR2A, AFT, AKR2, At4g35450, F15J1.20",Arabidopsis thaliana,2,AKR2A ankyrin repeat domain,"<a href=""https://www.rcsb.org/structure/5EID"">5EID</a>"
262,"AKR2B5, XYL1, XYLR",Yamadazyma tenuis,2.4,Crystal structure of the Lys-274 to Arg mutant of Candida tenuis xylose reductase (AKR2B5) bound to NAD+,"<a href=""https://www.rcsb.org/structure/1YE4"">1YE4</a>"
263,"AKR2B5, XYL1, XYLR",Yamadazyma tenuis,2.3,Crystal structure of the Lys-274 to Arg mutant of Candida tenuis xylose reductase (AKR2B5) bound to NADP+,"<a href=""https://www.rcsb.org/structure/1YE6"">1YE6</a>"
264,"AKR2E4, akr2e",Bombyx mori,1.3,Crystal structure of Bombyx mori aldo-keto reductase (AKR2E4) in complex with NADP,"<a href=""https://www.rcsb.org/structure/3WCZ"">3WCZ</a>"
265,"AKR2E5, 101740031",Bombyx mori,2.2,"Crystal structure of aldo-keto reductase (AKR2E5) of the silkworm, Bombyx mori","<a href=""https://www.rcsb.org/structure/5AZ0"">5AZ0</a>"
266,"AKR2E5, 101740031",Bombyx mori,2.3,Crystal structure of aldo-keto reductase (AKR2E5) complexed with NADPH,"<a href=""https://www.rcsb.org/structure/5AZ1"">5AZ1</a>"
267,"AKR4C13, AR3, 100857058, ZEAMMB73_Zm00001d038449",Zea mays,2.3,Crystal structure of maize AKR4C13 in complex with NADP and acetate,"<a href=""https://www.rcsb.org/structure/5JGW"">5JGW</a>"
268,"AKR4C7, 100037812, ZEAMMB73_Zm00001d042869",Zea mays,1.45,Crystal structure of the apo form of AKR4C7 from maize,"<a href=""https://www.rcsb.org/structure/5JH1"">5JH1</a>"
269,"AKR4C7, 100037812, ZEAMMB73_Zm00001d042869",Zea mays,1.72,Crystal structure of the holo form of AKR4C7 from maize,"<a href=""https://www.rcsb.org/structure/5JH2"">5JH2</a>"
270,"AKR4C8, At2g37760, F13M22, T8P21.6",Arabidopsis thaliana,1.4,Crystal structure of the plant stress-response enzyme AKR4C8,"<a href=""https://www.rcsb.org/structure/3H7R"">3H7R</a>"
271,"AKR4C9, At2g37770, F13M22, T8P21.32",Arabidopsis thaliana,1.25,Crystal structure of the plant stress-response enzyme AKR4C9,"<a href=""https://www.rcsb.org/structure/3H7U"">3H7U</a>"
272,"AKR4C13, AR3, 100857058, ZEAMMB73_Zm00001d038449",Homo sapiens,2.4,Structure of the aflatoxin aldehyde reductase in complex with NADPH,"<a href=""https://www.rcsb.org/structure/2BP1"">2BP1</a>"
273,"AKR7A2, AFAR, AFAR1, AKR7",Mus musculus,2.3,"mouse succinic semialdehyde reductase, AKR7A5","<a href=""https://www.rcsb.org/structure/2C91"">2C91</a>"
274,"Akr7a2, Afar, Akr7a5",Rattus norvegicus,1.38,Aflatoxin aldehyde reductase (AKR7A1) from Rat Liver,"<a href=""https://www.rcsb.org/structure/1GVE"">1GVE</a>"
275,"Akr7a3, Afar, Akr7a1",Homo sapiens,3,Crystal structure of human aflatoxin B1 aldehyde reductase member 3,"<a href=""https://www.rcsb.org/structure/2CLP"">2CLP</a>"
276,"AKR7A3, AFAR2",Zea mays,1.45,Crystal structure of maize AKR4C13 in P21 space group,"<a href=""https://www.rcsb.org/structure/5JGY"">5JGY</a>"
277,"AKR11A, iolS, yxbF, BSU39780, SS92ER",Bacillus subtilis,1.8,Structure of NADPH-dependent family 11 aldo-keto reductase AKR11A(apo),"<a href=""https://www.rcsb.org/structure/1PYF"">1PYF</a>"
278,"AKR11A, iolS, yxbF, BSU39780, SS92ER",Bacillus subtilis,2.35,Structure of NADPH-dependent family 11 aldo-keto reductase AKR11A(holo),"<a href=""https://www.rcsb.org/structure/1PZ0"">1PZ0</a>"
279,"AKR11B, yhdN, BSU09530",Bacillus subtilis,2.2,Structure of NADPH-dependent family 11 aldo-keto reductase AKR11B(holo),"<a href=""https://www.rcsb.org/structure/1PZ1"">1PZ1</a>"
280,"AKR11B4, GOX1615",Gluconobacter oxydans,2,Structure of the glycerol dehydrogenase AKR11B4 from Gluconobacter oxydans,"<a href=""https://www.rcsb.org/structure/3N2T"">3N2T</a>"
281,"AKR11C1, BH1011",Bacillus halodurans,1.25,aldo-keto reductase AKR11C1 from Bacillus halodurans (apo form),"<a href=""https://www.rcsb.org/structure/1YNP"">1YNP</a>"
282,"AKR11C1, BH1011",Bacillus halodurans,1.3,aldo-keto reductase AKR11C1 from Bacillus halodurans (holo form),"<a href=""https://www.rcsb.org/structure/1YNQ"">1YNQ</a>"
283,"AKR14A1, gpr, mgrA, yghZ, b3001, JW2970",Escherichia coli,2.38,The apo structure of a bacterial aldo-keto reductase AKR14A1,"<a href=""https://www.rcsb.org/structure/4AST"">4AST</a>"
284,"AKR14A1, gpr, mgrA, yghZ, b3001, JW2970",Escherichia coli,2.05,the complex Structure of the bacterial aldo-keto reductase AKR14A1 with NADP and citrate,"<a href=""https://www.rcsb.org/structure/4AUB"">4AUB</a>"
285,PR,Rauvolfia serpentina,2.31,"Crystal Structure of Perakine Reductase, Founder Member of a Novel AKR Subfamily with Unique Conformational Changes during NADPH Binding","<a href=""https://www.rcsb.org/structure/3UYI"">3UYI</a>"
286,PR,Rauvolfia serpentina,1.77,"Crystal Structure of Perakine Reductase, Founder Member of a Novel AKR Subfamily with Unique Conformational Changes during NADPH Binding","<a href=""https://www.rcsb.org/structure/3V0S"">3V0S</a>"
287,PR,Rauvolfia serpentina,2.33,"Crystal Structure of Perakine Reductase, Founder Member of a Novel AKR Subfamily with Unique Conformational Changes during NADPH Binding","<a href=""https://www.rcsb.org/structure/3V0T"">3V0T</a>"
288,PR,Rauvolfia serpentina,2.2,"Crystal Structure of Perakine Reductase, Founder Member of a Novel AKR Subfamily with Unique Conformational Changes during NADPH Binding","<a href=""https://www.rcsb.org/structure/3V0U"">3V0U</a>"
